Physician profile
Jack R Ross
NPI 1497779714
$2,891.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,308 · 2020: $902 · 2021: $682.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $474.27 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $361.86 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.41 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $284.16 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $248.55 | 2019-2021 | |
| Pfizer INC. | $245.99 | 2019-2020 | |
| Lilly USA, LLC | $210.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $167.23 | 2019-2021 | |
| Amgen INC. | $134.07 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $86.07 | 2019-2020 | |
| Astellas Pharma US INC | $80.54 | 2019-2021 | |
| Amarin Pharma, INC. | $44.64 | 2019 | |
| Vivus LLC | $33.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.84 | 2019-2020 | |
| Abbvie INC. | $27.33 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.91 | 2019 | |
| Zyla Life Sciences, INC. | $26.47 | 2019 | |
| Braemar Manufacturing, LLC | $20.84 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.64 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.20 | 2019 | |
| Abbott Laboratories | $14.85 | 2019 | |
| Radius Health, INC. | $13.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.